Key Takeaways & Executive Findings
- •• Fascia iliaca compartment block provides superior postoperative analgesia compared with femoral nerve block in femoral neck and intertrochanteric fractures, but not in subtrochanteric fractures. • Fascia iliaca compartment block significantly reduces inflammatory and stress responses, as well as morphine consumption, and shortens time to first ambulation and hospital stay. • Block type, fracture type, age ≥75 years, and ASA grade III are independent predictors of analgesic effect. • A nomogram prediction model was developed and validated to guide individualized analgesic strategy selection.
Abstract
BACKGROUND: Hip fracture is a common and serious injury in the elderly population, with postoperative pain management directly impacting rehabilitation quality and functional recovery. While peripheral nerve blocks have become an integral component of multimodal analgesia, systematic comparison of different blocking techniques across various types of hip fractures remains limited. OBJECTIVE: To compare the analgesic effects, safety profiles, and postoperative recovery impacts of fascia iliaca compartment block and femoral nerve block in different types of hip fracture surgeries. METHODS: A total of 180 patients scheduled for hip fracture surgery between January 2022 and June 2024 were enrolled and divided according to fracture type into femoral neck fracture group (n=60), intertrochanteric fracture group (n=60), and subtrochanteric fracture group (n=60). Patients in each group were randomly assigned to either fascia iliaca compartment block group or femoral nerve block group using a random number table, with 30 patients in each subgroup. Corresponding nerve blocks were performed preoperatively. Numeric pain scores were recorded immediately and at 6, 12, and 24 hours postoperatively; 24-hour morphine consumption, time to first ambulation, hospital stay, inflammatory markers (interleukin-6, tumor necrosis factor-α), stress response markers (cortisol, glucose), and adverse events were also assessed. Multivariate regression analysis identified factors influencing analgesic effect, and a nomogram prediction model was constructed. RESULTS AND CONCLUSION: In femoral neck and intertrochanteric fracture groups, the fascia iliaca compartment block subgroup had significantly lower numeric pain scores immediately and at 6 and 12 hours postoperatively compared with the femoral nerve block subgroup (P < 0.01). In the femoral neck fracture group, mean differences in pain scores were 0.86 (95%CI: 0.47-1.25), 0.90 (95%CI: 0.45-1.35), and 0.79 (95%CI: 0.30-1.28) at immediate, 6, and 12 hours, respectively; in the intertrochanteric fracture group, differences were 0.83 (95%CI: 0.43-1.23), 0.87 (95%CI: 0.44-1.30), and 0.70 (95%CI: 0.31-1.09). In these two groups, fascia iliaca compartment block significantly reduced 24-hour morphine consumption (P < 0.001), shortened time to first ambulation (P < 0.05), and reduced hospital stay (P < 0.05). In the subtrochanteric fracture group, no significant differences were observed between the two block techniques for any outcome (P > 0.05). Fascia iliaca compartment block significantly lowered inflammatory markers (interleukin-6, tumor necrosis factor-α) and stress markers (cortisol, glucose) compared with femoral nerve block (P < 0.001). Adverse event rates were comparable (P=0.825). Multivariate regression identified block type (β=-3.76, P < 0.001), fracture type (subtrochanteric β=5.47, P < 0.001), age ≥75 years (β=-1.75, P=0.022), and ASA grade III (β=2.32, P=0.016) as independent predictors of analgesic effect. The nomogram showed good calibration. Interleukin-6 levels positively correlated with hospital stay (r=0.42, P < 0.001) and time to first ambulation (r=0.38, P < 0.001). In conclusion, compared with femoral nerve block, fascia iliaca compartment block provides superior postoperative analgesia for femoral neck and intertrochanteric fractures, reduces inflammation and stress responses, and promotes early recovery; however, in subtrochanteric fractures, the two techniques are equivalent. Block type, fracture type, age, and ASA grade are independent factors influencing analgesic effect. The nomogram may guide individualized analgesic strategies.
1. Introduction
Hip fracture is one of the most common orthopedic injuries in the elderly population, causing severe pain and leading to long-term functional impairment and increased mortality, posing a major global public health challenge [1-3]. Perioperative pain management is a critical factor in improving outcomes for hip fracture patients. Evidence-based medicine shows that effective pain control facilitates early functional exercise, significantly reduces complications such as postoperative pulmonary infection, deep vein thrombosis, and delirium, shortens hospital stay, lowers 30-day readmission rates, and reduces healthcare resource consumption [4-5]. Currently, multimodal analgesia has become the standard perioperative pain management strategy for hip fractures, with regional nerve block techniques gaining attention due to their ability to reduce opioid use and related adverse effects [6-7].
Fascia iliaca compartment block and femoral nerve block are two commonly used regional block techniques for hip surgery. Anatomically, fascia iliaca compartment block involves injecting local anesthetic into the potential space between the fascia iliaca and the iliacus muscle, simultaneously blocking the femoral nerve, lateral femoral cutaneous nerve, and part of the obturator nerve, theoretically providing broader analgesic coverage [8]. In contrast, femoral nerve block directly targets the femoral nerve, primarily affecting pain transmission from the anterior and medial thigh, with relatively simpler operation [9]. The application of ultrasound guidance has significantly improved the success rate and safety of both techniques, but the choice between them remains controversial in clinical practice. Specifically, fascia iliaca compartment block, despite its broader coverage, requires more technical expertise and a longer learning curve; femoral nerve block is simpler but may risk incomplete analgesia. Additionally, differences in local anesthetic dosage, procedure time, and cost influence clinical decision-making, yet high-level evidence is lacking [10].
Loading authentic research manuscript (Pages 1–5)...
GUO Dongdong, GU Yongfu, ZHANG Kairan (2026). Effects of Fascia Iliaca Compartment Block and Femoral Nerve Block on Pain, Inflammation, and Stress Response in Hip Fracture Surgery. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21643
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the difference between fascia iliaca compartment block and femoral nerve block?
Fascia iliaca compartment block injects local anesthetic into the potential space beneath the fascia iliaca, blocking the femoral nerve, lateral femoral cutaneous nerve, and obturator nerve, providing broader analgesia. Femoral nerve block directly targets the femoral nerve, mainly affecting the anterior and medial thigh. Fascia iliaca block may offer more extensive coverage but requires more technical skill.
Which block is more effective for hip fracture surgery?
For femoral neck and intertrochanteric fractures, fascia iliaca compartment block provides superior postoperative analgesia compared with femoral nerve block, with lower pain scores and reduced morphine consumption. However, for subtrochanteric fractures, the two techniques show equivalent efficacy.
Does fascia iliaca compartment block reduce inflammation and stress response?
Yes, the study found that fascia iliaca compartment block significantly lowered levels of inflammatory markers (interleukin-6, tumor necrosis factor-α) and stress markers (cortisol, glucose) compared with femoral nerve block, suggesting a potential anti-inflammatory effect.
What factors influence the analgesic effect of nerve blocks in hip fracture surgery?
Independent predictors include block type, fracture type (subtrochanteric fractures associated with less benefit), age ≥75 years, and ASA grade III. These factors should be considered when selecting an analgesic strategy.
Can a nomogram predict the analgesic effect of nerve blocks?
Yes, the study constructed a nomogram prediction model incorporating block type, fracture type, age, and ASA grade, which showed good calibration and can help clinicians choose individualized analgesic approaches.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.